Associated Papers
SARS-CoV-2 Spike Protein XBB.1.5 Mutations Altered Four Conserved Antigenic Determinants.
Akbulut E et al.
International Journal of Molecular Sciences, 2026
Modeling the Mutational Effects on Biochemical Phenotypes of SARS-CoV-2 Using Molecular Fields.
Wang B et al.
Biomolecules, 2025
SARS-CoV-2 spike mutations alter structure and energetics to modulate ACE2 binding immune evasion and viral adaptation.
Ataya F et al.
Scientific Reports, 2025
An Italian Single-Center Genomic Surveillance Study: Two-Year Analysis of SARS-CoV-2 Spike Protein Mutations.
Cecchetto R et al.
International Journal of Molecular Sciences, 2025
Electronic Interactions Between the Receptor-Binding Domain of Omicron Variants and Angiotensin-Converting Enzyme 2: A Novel Amino Acid-Amino Acid Bond Pair Concept.
Adhikari P et al.
Molecules (basel, Switzerland), 2025
Impact of Missense Mutations on Spike Protein Stability and Binding Affinity in the Omicron Variant.
Mahase V et al.
Viruses, 2024
A systematic mutation analysis of 13 major SARS-CoV-2 variants.
Bai H et al.
Virus Research, 2024
Structural and genomic evolutionary dynamics of Omicron variant of SARS-CoV-2 circulating in Madhya Pradesh, India.
Dhankher S et al.
Frontiers in Medicine, 2024
Structural plasticity of omicron BA.5 and BA.2.75 for enhanced ACE-dependent entry into cells.
Lin J et al.
Journal of Biomolecular Structure & Dynamics, 2023
Surveillance for variants of SARS-CoV-2 to inform risk assessments.
Attar Cohen H et al.
Bulletin of the World Health Organization, 2023
Is the BNT162b2 vaccine still effective against the latest variant: XBB.1.5?
Erdag E et al.
Nigerian Journal of Clinical Practice, 2023
Variations in O-Glycosylation Patterns Influence Viral Pathogenicity, Infectivity, and Transmissibility in SARS-CoV-2 Variants.
Onigbinde S et al.
Biomolecules, 2023
Distinctive Features of the XBB.1.5 and XBB.1.16 Spike Protein Receptor-Binding Domains and Their Roles in Conformational Changes and Angiotensin-Converting Enzyme 2 Binding.
Sharma T et al.
International Journal of Molecular Sciences, 2023
The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex.
Peka M et al.
Future Virology, 2023
High-Throughput Molecular Dynamics-Based Alchemical Free Energy Calculations for Predicting the Binding Free Energy Change Associated with the Selected Omicron Mutations in the Spike Receptor-Binding Domain of SARS-CoV-2.
Bhadane R et al.
Biomedicines, 2022
A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs.
Chakraborty C et al.
Geroscience, 2022
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity.
Liu H et al.
International Journal of Molecular Sciences, 2022
SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19.
Liang HY et al.
Vaccines, 2022
The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants.
Pascarella S et al.
Pathogens (basel, Switzerland), 2022
A Class of Shark-Derived Single-Domain Antibodies can Broadly Neutralize SARS-Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape.
Feng B et al.
Small Methods, 2022
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization.
Guo H et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology, 2022
Finger stick blood test to assess postvaccination SARS-CoV-2 neutralizing antibody response against variants.
Lim SM et al.
Bioengineering & Translational Medicine, 2022
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe.
Thakur V et al.
Infection, 2022
A review on evolution of emerging SARS-CoV-2 variants based on spike glycoprotein.
Ghosh N et al.
International Immunopharmacology, 2022
Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants.
Yang Z et al.
Aging and Disease, 2022
Emerging Vaccine-Breakthrough SARS-CoV-2 Variants.
Wang R et al.
Acs Infectious Diseases, 2022
COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development.
Vo GV et al.
Microorganisms, 2022
Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity.
Prüβ BM
Frontiers in Bioscience (landmark Edition), 2022
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance.
Kimura I et al.
Cell Reports, 2022
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispecies.
Vellas C et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022
Mutations in human SARS-CoV-2 spike proteins, potential drug binding and epitope sites for COVID-19 therapeutics development.
Guruprasad K
Current Research in Structural Biology, 2022
The Emergence of SARS-CoV-2 Variants With a Lower Antibody Response: A Genomic and Clinical Perspective.
Biswas S et al.
Frontiers in Medicine, 2022
SARS-CoV-2 variants: Impact on biological and clinical outcome.
Mahilkar S et al.
Frontiers in Medicine, 2022
The biological and clinical significance of emerging SARS-CoV-2 variants.
Tao K et al.
Nature Reviews. Genetics, 2021
SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
Darvishi M et al.
Gene Reports, 2021
SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape.
Yang L et al.
International Journal of Molecular Sciences, 2021
Structure-Function Analysis of Resistance to Bamlanivimab by SARS-CoV-2 Variants Kappa, Delta, and Lambda.
Liu S et al.
Journal of Chemical Information and Modeling, 2021
Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.
Lennerstrand J et al.
Viruses, 2021
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution.
Zahradník J et al.
Nature Microbiology, 2021
The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines.
Liu H et al.
Biorxiv : the Preprint Server for Biology, 2021
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries.
Wang R et al.
Genomics, 2021
Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.
Wilton T et al.
Msystems, 2021
Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis.
Ortega JT et al.
Excli Journal, 2021